| __timestamp | Arrowhead Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 5280000 |
| Thursday, January 1, 2015 | 57410147 | 7148000 |
| Friday, January 1, 2016 | 41454452 | 19594000 |
| Sunday, January 1, 2017 | 31690298 | 22894000 |
| Monday, January 1, 2018 | 52968505 | 50337000 |
| Tuesday, January 1, 2019 | 81048686 | 109450000 |
| Wednesday, January 1, 2020 | 128874979 | 90450000 |
| Friday, January 1, 2021 | 206342000 | 104128000 |
| Saturday, January 1, 2022 | 297307000 | 108630000 |
| Sunday, January 1, 2023 | 353188000 | 134951000 |
| Monday, January 1, 2024 | 505870000 |
Unleashing insights
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Rhythm Pharmaceuticals, Inc. have demonstrated contrasting approaches to research and development (R&D) spending. From 2014 to 2023, Arrowhead's R&D expenses surged by over 1,800%, peaking in 2023. This aggressive investment strategy underscores their commitment to pioneering new treatments. In contrast, Rhythm Pharmaceuticals showed a more measured increase, with R&D spending growing by approximately 2,500% from 2014 to 2022, before data became unavailable for 2024. This suggests a strategic pause or shift in focus. The data highlights Arrowhead's consistent upward trend, while Rhythm's trajectory, though impressive, leaves questions about future directions. As these companies navigate the ever-evolving pharmaceutical landscape, their R&D investments will likely play a pivotal role in shaping their competitive edge.
Research and Development Expenses Breakdown: Novartis AG vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Amgen Inc. and Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Vertex Pharmaceuticals Incorporated vs Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Neurocrine Biosciences, Inc. vs Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Jazz Pharmaceuticals plc vs Arrowhead Pharmaceuticals, Inc.
Research and Development Investment: Madrigal Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Opthea Limited vs Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Rhythm Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.
Xenon Pharmaceuticals Inc. or Arrowhead Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Viridian Therapeutics, Inc.